scispace - formally typeset
J

Jens Hoeppner

Researcher at University of Freiburg

Publications -  93
Citations -  2284

Jens Hoeppner is an academic researcher from University of Freiburg. The author has contributed to research in topics: Esophageal cancer & Medicine. The author has an hindex of 23, co-authored 85 publications receiving 1771 citations. Previous affiliations of Jens Hoeppner include University Medical Center Freiburg & Freiberg University of Mining and Technology.

Papers
More filters
Journal ArticleDOI

Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface.

TL;DR: The relationship between current biological and clinical concepts such as cell migration modes, tumour budding and epithelial-mesenchymal transition (EMT) remains unclear in several aspects, especially for the'real' situation in human cancer as mentioned in this paper.
Journal ArticleDOI

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

TL;DR: The ESOPEC trial compares perioperative chemotherapy according to the FLOT protocol to neoadjuvant chemoradiation according toThe CROSS protocol in multimodal treatment of non-metastasized recectable adenocarcinoma of the esophagus and the gastroesophageal junction to identify the superior protocol with regard to patient survival, treatment morbidity and quality of life.
Journal ArticleDOI

Impact of different crystalloid volume regimes on intestinal anastomotic stability.

TL;DR: It is demonstrated for the first time in a systematic investigation, that the quantity of crystalloid infusion, applied intraoperatively, has a significant impact on functional (bursting pressure) and structural (hydroxyproline) stability of intestinal anastomoses in the early postoperative period.
Journal ArticleDOI

Postpancreatectomy hemorrhage--incidence, treatment, and risk factors in over 1,000 pancreatic resections.

TL;DR: High-risk histopathology, age, transfusion, pancreatic fistula, postpancreatectomy hemorrhage and pancreatojejunostomy in pancreatoduodenectomies were independent predictors of mortality.
Journal ArticleDOI

Circulating tumor cells found in patients with localized and advanced pancreatic cancer.

TL;DR: The ability of a simple new low-cost filtration device to capture, cytologically identify, and genetically analyze CTCs suggests a possible tool for the diagnosis and characterization of genetic alterations of PDAC.